Drug companies agree to cut price of HPV vaccine to developing countries to increase accessibility.

BMJ (Clinical research ed.)

Volumn 346, Issue , 2013, Pages

  Gulland, Anne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HUMAN; NOTE; ORGANIZATION AND MANAGEMENT; PAPILLOMAVIRUS INFECTION;

DEVELOPING COUNTRIES; DRUG COSTS; DRUG INDUSTRY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES;

EID: 84879484195     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f3025     Document Type: Note

References (0)